LOGO
LOGO

FDA Calendar - Unicycive Therapeutics, Inc.

Company Name Unicycive Therapeutics, Inc.
UNCY
Drug Name Oxylanthanum Carbonate (Resubmitted NDA)
Event Name FDA decision on Oxylanthanum Carbonate for the treatment of hyperphosphatemia in CKD patients on dialysis
Event Date 06/29/2026
Outcome Date
Outcome Pending
Drug Status The FDA had issued a Complete Response Letter in June 2025, citing deficiencies previously identified at a third-party manufacturing vendor unrelated to Oxylanthanum Carbonate
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar
RELATED NEWS (Unicycive Therapeutics, Inc.)
Editors Pick
waltdisney 06052026 lt

Disney Q2 Profit Down, Sees Earnings Growth In FY26, FY27; Plans At Least $8 Bln Buyback; Stock Up

May 06, 2026 07:32 ET
gamestop 04052026 lt

GameStop Offers To Buy EBay In $55.5 Bln Cash, Stock Deal; EBay Shares Gain

May 04, 2026 06:05 ET
colgate 01052026 lt

Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up

May 01, 2026 08:09 ET
humana 29042026 lt

Humana Cuts FY26 EPS View, Backs Adj. Earnings Forecast After Weak Q1 Profit; Stock Drops

April 29, 2026 06:37 ET
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap